Skip to main content
OpenTrials

Clinical trial condition

Blastic Plasmacytoid Dendritic Cell Neoplasm

Explore clinical trials studying Blastic Plasmacytoid Dendritic Cell Neoplasm. Study availability and eligibility vary by location and protocol.

31 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Blastic Plasmacytoid Dendritic Cell Neoplasm trial results

Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions
ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
View all 31 locations
View Trial Details
Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

NCT02113982

Conditions
Acute Myeloid Leukemia (AML), Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • H. Lee Moffiitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

NCT02730312

Conditions
Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blast Crisis, +39 more
Locations
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
View Trial Details

Related conditions